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Key Points . . .
➤ Use of complementary and alternative medicine (CAM) therapies
is common among women diagnosed with breast cancer.
➤ Use of CAM was associated with patients’ use of chemotherapy,
higher education, and not being satisfied with their primary phy-
sician.
➤ Assessment of use of CAM therapies is an important consideration
and may have implications for treatments being administered.
➤ Effective implementation of CAM therapies may positively re-
lieve physical symptoms and psychological distress.
Purpose/Objectives: To estimate the frequency of use
of complementary and alternative medicine (CAM)
therapies among women diagnosed with breast cancer
and to identify demographic and clinical factors associ-
ated with CAM use in these patients.
Design: A descriptive, cross-sectional survey.
Sample: A convenience sample of 105 predominantly
Caucasian women (
—
X  age = 59 years) with a diagnosis of
breast cancer was recruited from the Tampa Bay area
and a rural midwestern area.
Methods: Using the “Use of Complementary Therapies
Survey,” frequency of CAM use was calculated for 33 in-
dividual therapies listed on the survey and among three
survey-defined subscales of CAM therapies (i.e., diet and
nutritional supplements, stress-reducing techniques, and
traditional and ethnic medicines).
Main Research Variables: [Au from RM: Please provide.]
Findings: Among diet and nutritional supplements,
64% of all participants reported regular use of vitamins
and minerals and 33% regularly used antioxidants, herbs,
and health foods. Among stress-reducing techniques,
49% of all participants regularly used prayer and spiritual
healing, followed by support groups (37%) and humor or
laughter therapy (21%). Traditional and ethnic medicine
therapies rarely were used with the exception of mas-
sage, which was used at least once after diagnosis by
27% of all participants. More frequent CAM use was ob-
served among study participants who had undergone
previous chemotherapy treatment and those with more
than a high school education. Also, being less satisfied
with their primary physician was associated with pa-
tients’ more frequent CAM use.
Conclusions: CAM use is increasing among women
with breast cancer, and frequency of specific use ac-
cording to type of CAM is higher than reported from other
studies. Use increased in patients who had undergone
chemotherapy and in those with a high school educa-
tion.
Implications for Nursing: Oncology nurses are in a key
position to identify what treatments patients are using
and implement CAM therapies that can be helpful to re-
lieve patient symptoms related to treatment and psy-
chological distress.
Frequency of Use of
Complementary and Alternative Medicine
in Women With Breast Cancer
Cecile A. Lengacher, RN, PhD, Mary P. Bennett, DNSc, RN, Kevin E. Kip, PhD,
Rosemary Keller, PhD, RN, Melisa S. LaVance, MSN, RN, FNP,
Lynette S. Smith, MSN, RN, FNP, and Charles E. Cox, MD
Cassileth, 1998; Ernst, Willoughby, & Weihmayer, 1995).
Use of CAM by women with breast cancer is believed to be
increasing, but limited research exists on the frequency and
predictors of CAM use in this population.
With increasing fears of morbidity and mortality, women
with breast cancer may be seeking a variety of CAM treat-
ments (VandeCreek, Rogers, & Lester, 1999). Estimates
suggest that breast cancer will account for 31% of all new
cancer cases among women in 2002, with approximately
203,500 new cases nationwide and 13,100 in Florida alone
(Jemal, Thomas, Murray, & Thun, 2002). Because of the
possible physical, emotional, and financial impact of the
C omplementary and alternative medicine (CAM) is de-fined as methods used in the diagnosis, treatment, orprevention of disease that complement mainstream
medicine, as opposed to alternative therapies, which are
used as a direct substitute for mainstream medicine (Ernst &
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use of various CAM therapies by this population, estimat-
ing the frequency and predictors of CAM use among
women with breast cancer is of scientific and public health
importance.
Practitioners of conventional medicine have justifiably
criticized use of most CAM therapies for the relative lack of
peer-reviewed, scientifically conducted analyses. Neverthe-
less, CAM use by the general public has increased to the ex-
tent that medical science should not continue to ignore this
increased use and the possible adverse effects that may occur
with some CAM use (Hennekens, Buring, & Peto, 1994; Of-
fice of Technology Assessment, 1990). Documented CAM
use by patients in general is reported to be as high as 45%,
yet the role of CAM in patient care has had little scientific
support. However, studies at the National Cancer Institute
(NCI) and the National Center for Complementary and Alter-
native Medicine are beginning to have an impact on this sci-
entific evidence (Lerner & Kennedy, 1992; Murray & Rubel,
1992; Risberg, Lund, Wist, Kaasa, & Wilsgaard, 1998;
Verhoef, Russell, & Love, 1994). Research suggests that up to
64% of individuals with cancer use CAM in addition to their
prescribed cancer treatments (Ernst & Cassileth, 1998).
Literature Review
Use of Complementary and Alternative
Medicine in Breast Cancer
Compared to CAM use by patients with cancer as a whole,
fewer studies have examined the prevalence or correlates of
CAM use among patients with breast cancer. A meta-analysis
of studies of CAM used for treatment with breast cancer re-
vealed few well-controlled studies with adequate end-point
data (Jacobson, Workman, & Kronenberg, 2000). The 10
studies included in the analysis were grouped according to
whether CAM was used to alter disease progression, alleviate
symptoms caused by the disease, relieve or prevent treatment
side effects, or improve immune function.
Studies conducted outside of the United States: Five of
the studies were conducted outside the United States, three
in Canada and two in Europe. The first study, conducted in
Canada, studied patients with breast cancer (35 used CAM
and 17 did not). The most frequent types of CAM used
were meditation and relaxation (64%), vitamins or tonic
(58%), spiritual and faith healing (54%), herbal remedies
(50%), special foods and diets (27%), immune therapies
(23%), massage therapy (19%), detoxification (17%), and
shark cartilage (8%) (Balneaves, Kristjanson, & Tataryn,
1999).
The second study, with a larger sample, also was con-
ducted in Canada. It examined the prevalence of CAM use
by 422 breast cancer survivors and compared characteristics
of users of CAM with nonusers (Boon et al., 2000). Users of
CAM had greater incomes and were younger, more educated,
and more likely being treated with chemotherapy compared
to nonusers. Overall, 67% reported using some form of CAM
and 16% indicated they currently adhered to a CAM treat-
ment protocol. The top 10 CAM therapies were vitamins and
minerals (50%), herbal remedies (25%), green tea (17%), spe-
cial foods (15%), essiac [Author: correct word?] (15%),
body work (e.g., Reiki, massage, therapeutic touch) (14%),
meditation (10%), shark cartilage (5%), homeopathy (4%),
and faith healing (3%). These top therapies were used by
62% of the respondents. CAM was used most often in an at-
tempt to boost the immune system.
The third study was a qualitative study conducted in
Canada. It explored the perceptions and experiences related
to CAM use in 36 women diagnosed with breast cancer
(Boon, Brown, Gavin, Kennard, & Stewart, 1999). Partici-
pants identified a wide range of therapies, but the frequency
of use was not systematically reported. Barriers to use were
identified as cost, access, and time.
The fourth study, completed in Europe, examined CAM
use among 242 patients with breast cancer who were receiv-
ing conventional treatment (Crocetti et al., 1998). Results
showed that after one year, 16% of patients used CAM after
diagnosis compared to 9% before diagnosis. The main reason
identified for using CAM was physical distress. The most
common therapies among this European sample were home-
opathy, manual healing, herbals, and acupuncture.
The fifth study conducted in England examined preva-
lence of CAM use in 714 patients with breast cancer (Rees et
al., 2000). Results showed that 22% of patients used various
CAM therapies in the prior 12 months; the highest reported
use was aromatherapy massage (9%); chiropractic or osteopa-
thy (6%); relaxation, yoga, and meditation (6%); and heal-
ing (5%). [Au from RM: What kind of healing?]
U.S. studies: Five studies examined prevalence or patterns
of use of alternative therapies in women with breast cancer in
the United States. Two of the studies examined use CAM use
in patients with breast cancer compared with other popula-
tions. The first, a longitudinal cohort study of 86 patients
with breast cancer from the San Francisco area reported that
72% of these women were using at least one form of CAM
(Adler & Fosket, 1999). However, CAM use was not depen-
dent on the diagnosis of breast cancer because 69% of the par-
ticipants reported using at least one CAM therapy before di-
agnosis. CAM use appeared to be age-related because 78%
of young women reported using CAM before diagnosis,
compared to 58% of older women. Six months later [Au from
RM: later than what? Do you mean postdiagnosis?], 65%
of the women were using some form of CAM. A limitation of
this study was that it did not report the specific types of CAM
therapies that the women used.
The second study conducted in the United States exam-
ined types and prevalence of use of conventional and CAM
therapies by women with early-stage breast cancer in four
ethnic groups (N = 379) (Lee, Lin, Wrensch, Adler, & Eisen-
berg, 2000). The most commonly reported CAM therapies
were dietary therapies (27%), spiritual healing (24%), herbal
remedies (13%), physical methods (14%), and psychological
methods (9%). Use ranged from 21%–36%, with ethnic differ-
ences in types of CAM used. African Americans most often
reported use of spiritual healing (36%), Chinese subjects
used herbal remedies (22%), Latinas used dietary therapies
(30%) and spiritual healing (26%), and Caucasians reported
using more dietary methods (35%) and physical methods
(e.g., acupuncture, massage) (21%). This was the first study
examining prevalence of use by ethnicity.
A third, statewide study [Author: please identify state] of
480 women examined retrospectively types of CAM thera-
pies used in patients with newly diagnosed breast cancer
(Burstein, Gelber, Guadagnoli, & Weeks, 1999). Unlike the
San Francisco study, only 11% of this sample reported us-
ing CAM prior to their breast cancer diagnosis. After breast
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surgery, 29% began to use CAM. Findings indicated that
use of psychological therapies (e.g., relaxation, self help,
spiritual healing, imagery, biofeedback, hypnosis) decreased
following surgery (29% compared to 22%). Use of healing
therapies (e.g., megavitamins, herbal medicine, massage,
chiropractic, macrobiotic, acupuncture, energy healing, ho-
meopathy, folk remedies) also decreased following surgery
(28% compared to 19% after surgery). Other interesting
data from this study indicated that three months after sur-
gery, CAM use was associated with depression, fear of re-
currence of cancer, lower scores for mental health, and more
physical symptoms. The authors concluded that CAM use
should alert healthcare providers to the possibility of unre-
lieved physical symptoms and accompanying symptoms of
depression.
Use of CAM compared to other populations: The fourth
and fifth studies conducted in the United States reported on
CAM use in people with breast cancer compared to other
populations. In a study comparing the CAM use in patients
with breast cancer to use in the general population,
VandeCreek et al. (1999) reported that the therapies most fre-
quently used by patients with breast cancer were prayer
(76%), exercise (38%), spiritual healing (29%), and
megavitamins (23%). In comparison to a general population
sample, patients with breast cancer were using a wider range
of alternative therapies. The researchers concluded that the
morbidity and mortality associated with breast cancer moti-
vated this increased use.
The last study compared CAM use in people with breast
cancer with people who had other types of cancers. The au-
thors reported that CAM use among patients with breast can-
cer was high (84%; n = 117) compared to those with other
malignancies (66%; n = 132) (Morris, Johnson, Homer, &
Walts, 2000). In addition, people with breast cancer were far
more likely to be consistent users compared with those with
other tumor sites. The most frequently used therapies for pa-
tients with breast cancer were nutrition (65%), massage
(57%), herbs (49%), relaxation (41%), chiropractic (43%), and
acupuncture (31%).
Although CAM therapies were examined in the previ-
ously mentioned studies in women with breast cancer, spe-
cific therapies were systematically specified. Many of the
studies identified that users of CAM were younger, more
educated, and had previously used CAM. The most com-
monly used therapies by women with breast cancer were
nutrition and herbs, prayer and spiritual healing, acupunc-
ture, and relaxation. The most commonly reported reasons
for use were to relieve psychological (e.g., depression or
anxiety) and physical (e.g., pain) distress and to boost the
immune system. Psychological distress, physical distress,
and fear of recurrence appear to be related to increased
CAM use. A limitation of many of the studies is that they
required participants to retrospectively recall of CAM thera-
pies used over several years. Although these 10 studies ex-
amined patterns and frequency of CAM use in patients with
breast cancer in North America and Europe, a shortage of
reliable information exists about the specific types of thera-
pies being used. In addition, little data exist regarding
which demographic and clinical factors are associated with
CAM therapy use in patients with breast cancer. Therefore,
the purpose of the current study was to estimate the fre-
quency of use and describe specific types of CAM therapies
used among women diagnosed with breast cancer and to
identify demographic and clinical factors associated with
CAM use in these patients.
Methods
Study Sample and Design
A descriptive, cross-sectional survey was used to deter-
mine the frequency of CAM use in women with breast cancer.
Subjects were recruited from midwestern community groups
and breast cancer clinics at H. Lee Moffitt Cancer Center and
Research Institute in Tampa, FL, and from community
groups in Tampa. RNs recruited participants and explained
the study to them. Subjects could complete the survey on
site or to return it by mail. The survey was anonymous and
the principal investigators maintained data in a locked file.
The only inclusion criteria were a diagnosis of breast cancer
and the ability to read English.
Instrument
The “Use of Complementary Therapies Survey” was based
on an original study completed using the Complementary
Therapy Rating Scale (CTRS) (Bennett & Lengacher, 1999).
The original CTRS was modified by adding items based on
the classifications of complementary therapies identified by
the Office of Alternative Medicine (OAM). According to
OAM, alternative medical practices can be grouped loosely
into six basic categories: diet and nutritional lifestyle
changes, herbal medicine, bioelectromagnetic applications,
manual healing, mind-body control, and pharmacologic and
biologic treatments. Content validity of the CTRS first was
determined by a content validity index (CVI) and found to be
0.89. Thirty-two items had a CVI of 1.0, and six items had a
CVI of 0.33. The six items with a CVI of 0.33 were deleted
from the final survey. One item, aromatherapy, was added at
the recommendation of reviewers. Based on the review of the
content areas, the items were grouped into three major
subscales: diet and nutritional supplements, stress-reducing
therapies, and traditional and ethnic medicines. Use of each
CAM therapy from the complete survey was rated using a
four-point Likert scale with points distributed as follows: 1 =
never, 2 = once, 3 = several times, and 4 = regular basis. The
survey contained a total of 33 items, and the possible range
of points on the piloted inventory could vary from 33–132.
Reliability was determined using coefficient alpha. For the
entire survey, the alpha was 0.86. For the individual
subscales, alphas were 0.67 for the 6 items in the diet and
nutritional supplements subscale, 0.79 for the 11 items in the
stress-reducing techniques subscale, and 0.80 for the 16
items in the traditional and ethnic medicines subscale.
In addition to information concerning frequency of CAM
use, a second part was added to the survey to gain informa-
tion on usefulness of individual therapies and if the women
had discussed the therapies with their healthcare providers.
Patient demographics (i.e., age, ethnicity, education, em-
ployment status, marital status, religion, income, reported
clinical treatments, and family history of breast cancer) also
were collected.
Data Analysis
Frequency of use was calculated for each individual CAM
therapy, as well as for the three survey-defined subscales of
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CAM therapies. Logistic regression analysis was used to esti-
mate the relative odds of regular use or any use (with yes or no
answers) of the three types of CAM therapies in relation to
baseline demographic and clinical characteristics. Full models
were fit that included a set of nine baseline demographic and
clinical characteristics. In addition, ordinary least squares re-
gression models were fit to identify independent predictors of
CAM therapy use. The three dependent variables were the
proportion of participants who used diet and nutritional
supplements, stress-reducing techniques, or traditional and
ethnic medicine following breast cancer diagnosis. Predictors
were selected by stepwise regression using entry and
retainment p values of 0.1.[Author from RM: Why did you
not use the standard value of 0.05?] All analyses were per-
formed with the SAS® System, version 8.0 (SAS Institute,
Cary, NC).
Results
Study Participants
Analysis of the sociodemographic characteristics revealed
that 105 of the 125 women who were asked to participate
completed the surveys, for an 86% response rate. Demo-
graphic and clinical history characteristics of the study popu-
lation are presented in Table 1. The mean age was 59. Most
participants (95%) were Caucasian and 4% were African
American, with 1% unknown. The participants were very
educated, with only 3% having less than a high school edu-
cation, 25% having graduated from high school, and 72%
having some college education. Most of the subjects lived in
an urban or suburban area (61%), with 39% living in a small
town or rural area. Employment status demonstrated that 44%
worked either part-time or full-time and 39% were retired.
Annual household income was high, with 30% in the
$25,000–$50,000 range and 55% in the $50,000 to more
than $100,000 range. Self-reported clinical data on type of
cancer indicated 57% had ductal carcinoma, with 17% lobu-
lar; 54% reported they had previously received chemotherapy
and 10% were currently receiving chemotherapy; 52% re-
ported having received radiation previously; and 5% cur-
rently were being treated with radiation.
Frequency of Use of Complementary and
Alternative Medicine Therapies
About two-thirds of all participants reported using vitamins
and minerals on a regular basis, whereas antioxidants were
used less regularly by a third of all participants (see Table 2).
Herbs, health foods, and special diets were used infrequently.
Among participants who reported using diet and nutritional
supplements since being diagnosed with breast cancer, the
majority indicated that they had discussed this use with their
doctor. Half or more [Author: Do you mean “more than half”
or “at least half”?] of all participants who reported using diet
and nutritional supplements since being diagnosed indicated
they had not used these therapies prior to diagnosis.
Overall, stress-reducing techniques were used less fre-
quently than diet and nutritional supplements, although two-
thirds of all participants reported using at least one stress-
reducing technique on a regular basis. Prayer and spiritual
healing was the most common stress-reduction technique
used regularly (49%), followed by support groups (37%) and
humor or laughter therapy (21%). Unlike the use of diet and
Table 1. Demographic and Clinical History Characteristics of
Study Population
Characteristic
Age (years)
X(SD) = 59(12)
Ethnicity
Caucasian
African American
Other
Years of education
Less than high school
High school
Some college
Bachelor’s degree
Master’s degree
Doctoral degree or other
advanced degree
Area of residence
Urban
Suburban
Small town
Rural
Work status
Employed full-time
Employed part-time
Unemployed
Retired
Disabled
Other
Annual household income
< $25,000
$25,000–$50,000
> $50,000–$75,000
> $75,000–$100,000
> $100,000
Family history of cancer
Type of breast cancer
Ductal
Lobular
Unknown
Type of treatment
Surgery previously received
Chemotherapy previously
received
Chemotherapy currently
being received
Radiation previously received
Radiation currently being
received
Other medical treatment
previously received
Other medical treatment
currently being received
n
–
)98
004
001
003
025
027
028
012
005
019
044
031
009
033
013
010
041
002
005
014
028
026
016
011
044
049
015
022
104
057
010
055
005
020
015
%
–
95
04
01
03
25
27
28
12
05
18
43
30
09
32
12
10
39
02
05
15
30
28
16
11
42
57
17
26
99
54
10
52
05
19
14
N = 105
[Author: When added, the numbers in the n column do not
total the N value you have given (105). However, for all cat-
egories except “Family history of cancer” and the items under
“Type of treatment,” the percentages total 100. How can this
be if the total sample is not represented? If all numbers are
correct, please provide wording to be used as a footnote to
explain why this is so.]
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nutritional supplements, most users of several stress-reducing
techniques (e.g., art therapy, music therapy, humor or laugh-
ter therapy, guide imagery, prayer and spiritual healing) did
not discuss this use with their doctor. A large percentage of
users of stress-reducing techniques had prior experience with
these therapies before diagnosis, whereas users of support
groups and guided imagery rarely had experience with these
stress-reducing techniques prior to breast cancer diagnosis.
The 16 CAM therapies classified as traditional and ethnic
medicines rarely were used by study participants with the ex-
ception of massage, which was used at least once after diagno-
sis by 27% of all participants. Similar to the use of stress-reduc-
tion techniques, most users of traditional and ethnic medicines
did not discuss this use with their doctor.
Table 2. Use of Complementary and Alternative Medicine (CAM) Therapies
CAM Therapiesa
Diet and nutritional supplements
Special diets (e.g., macrobiotic)
Vitamins and minerals (e.g., selenium)
Cleansing or detoxification regimens
Health foods (e.g., barley grass)
Herbs (e.g., ginkgo biloba)
Antioxidants
At least one of the six listed above
Percent of therapies used since diagnosis
—
X (SD) = 27(23)
Stress-reducing techniques
Art therapy
Relaxation techniques
Music therapy
Humor or laughter therapy
Guided imagery
Counseling
Support group
Prayer and spiritual healing
Biofeedback
Hypnosis
Yoga and meditation
At least 1 of the 11 listed above
Percent of therapies used since diagnosis
—
X (SD) = 27(42)
Traditional and ethnic medicines
Acupuncture
Homeopathic remedies
Ethnic medicines (e.g., Chinese)
Acupressure
Massage
Chiropractic
Reflexology
Therapeutic touch
Aromatherapy
Ozone or hydrogen peroxide therapy
Metabolic therapy
Chelation therapy
Naturopathy
Magnetic therapy
Electro-stimulation
Colored light treatments
At least 1 of the 16 listed above
Percent of therapies used since diagnosis
—
X (SD) = 6(10)
Use Since Breast Cancer Diagnosis
n
14
77
02
15
20
41
81
13
43
31
45
27
20
53
62
03
01
19
82
02
02
03
02
28
11
06
07
11
01
01
01
03
04
05
–
39
At least once
%
13
73
02
15
20
39
77
12
41
30
43
26
19
51
59
03
01
18
78
02
02
03
02
27
10
06
07
10
01
01
01
03
04
05
–
37
Regularly
n
10
67
01
10
14
35
71
03
16
12
22
06
04
38
51
02
–
06
69
–
01
01
01
06
02
02
02
–
–
–
–
01
01
–
–
12
%
10
64
01
10
13
33
68
03
15
11
21
06
04
37
49
02
–
06
66
–
01
01
01
06
02
02
02
–
–
–
–
01
01
–
–
11
Used Treatment
Before Diagnosis
Discussed Use
With Doctor
nb
09
53
–
08
11
29
–
03
21
05
12
07
14
37
20
–
–
07
–
–
–
–
–
08
02
–
02
01
–
–
–
–
–
–
–
–
%
69
83
–
67
69
81
–
30
64
24
36
37
82
86
43
–
–
50
–
–
–
–
–
32
29
–
40
11
–
–
–
–
–
–
–
–
nb
04
35
–
02
06
17
–
07
17
19
29
06
09
06
53
–
–
05
–
–
–
–
–
11
06
05
02
04
–
–
–
–
–
–
–
–
%
033
053
–
014
035
049
–
064
046
073
076
023
053
015
098
–
–
036
–
–
–
–
–
048
075
100
033
067
–
–
–
–
–
–
–
–
a Missing cases exist for some variables. [Author: n totals do not equal the N in this table, either. Can I add to this footnote wording
that indicates that patients could be using more than one type of CAM therapy?]
b Data in the columns regarding discussion of CAM use with doctor and CAM use before diagnosis are restricted to CAM thera-
pies with at least five respondents who reported usage following diagnosis of breast cancer.
—
 [Author from RM: Pkease ckarify—is this percent
of patients using therapies or percent of therapies
used?]
ONF – VOL 29, NO 10, 2002
6
Predictors of Use of Complementary and
Alternative Medicine Therapies
Table 3 lists predictors of CAM use in the form of odds ra-
tios. No demographic or clinical factor was associated with
CAM use below the conventional p value of 0.05. The most
consistent evidence suggestive of an association was for previ-
ous chemotherapy treatment. The estimated odds of regular use
of diet and nutritional supplements and stress-reducing tech-
niques were approximately 2.5 times higher among partici-
pants who previously had received chemotherapy compared to
those who had not. A similar result was observed for use of tra-
ditional and ethnic medicines. In addition, having more than a
high school education consistently was suggested as increasing
the likelihood of using CAM.
When the three subscales of CAM therapies were modeled
as a continuous variable (i.e., percent of therapies used), hav-
ing more than a high school education and previously re-
ceiving chemotherapy were associated with more frequent
use of diet and nutritional supplements and stress-reducing
techniques (see Table 4). In addition, a trend (not significant)
occurred in that participants who were very satisfied or com-
pletely satisfied with their primary physician were less likely
to use stress-reducing techniques. Finally, when considering
the percent use of all 33 CAM therapies, having more than a
high school education and previous receipt of chemotherapy
Table 3. Logistic Regression Analysis of Predictors of Use of CAM Therapies
Predictor of Use
Age (per five years)
At least some college (versus high
school or less)
Urban or suburban residence (versus
rural or small town)
Employed full or part-time
Family history of cancer
Very satisfied or completely satisfied
with primary physician
Chemotherapy previously received
Radiation previously received
Other medical treatment previously
received
Model 1
Regular Use of Diet and
Nutritional Supplements
Model 2
Regular Use of Stress-
Reducing Techniques
Model 3
Any Use of Traditional and
Ethnic Medicines
OR
1.10
1.83
1.04
0.57
1.73
0.55
*
*2.53*
1.20
1.15
95% CI
0.85, 1.42
0.59, 5.72
0.39, 2.78
0.19, 1.69
0.64, 4.66
0.19, 1.59
0.86, 7.44
0.47, 3.06
0.36, 3.67
OR
1.12
1.96
*0.36*
0.49
1.00
0.63
*2.50*
1.58
1.84
95% CI
0.87, 1.45
0.61, 6.28
0.13, 1.01
0.16, 1.46
0.38, 2.63
0.21, 1.83
0.86, 7.34
0.61, 4.12
0.54, 6.27
OR
1.14
*2.77*
1.91
1.20
*0.42*
0.73
*2.88*
1.25
1.37
95% CI
0.88, 1.48
0.84, 9.14
0.69, 5.27
0.40, 3.60
0.15, 1.14
0.26, 2.06
0.97, 8.57
0.49, 3.20
0.46, 4.08
N = 93
* p < 0.10. OR—odds ratio; CI—confidence interval [Author from RM: Please explain why p < 0.1 was used instead of 0.05; also,
why is there a distinction of some items that are < 0.1? Please explain here and in the text.]
Table 4. Least Squares Regression Analysis of Predictors of Use of CAM Therapies
Predictor of Use
Age (per year)
At least some college (versus high
school or less)
Urban or suburban residence (versus
rural or small town)
Employed full or part-time
Family history of cancer
Very satisfied or completely satisfied
with primary physician
Chemotherapy previously received
Radiation previously received
Other medical treatment previously
received
Model 1 (N = 100)
Percent Use of the Six
Listed Diet and Nutritional
Supplements
Model 2 (N = 98)
Percent Use of the 11
Listed Stress-Reducing
Techniques
Model 3 (N = 98)
Percent Use of All 33
Listed CAM Therapies
t
–
1.88
–
–
–
–
2.10
–
–
ß
–
9.34
–
–
–
–
*9.41*
–
–
ß
–
***19.20***
–
–
–
–12.16*
07.44
–
–
t
–
–3.80
–
–
–
–2.56
–1.70
–
–
ß
–
**–8.60**
–
–
–
–4.90
*–5.75*
–4.41
–
t
–
–2.86
–
–
–
–1.75
–2.21
–1.70
–
*p < 0.05; **p < 0.01; *** p < 0.001
ß—Beta-coefficient from regression model
[Author: The “Did not enter model item”—does this mean that these aspects did not predict use of CAM or that no statistics were
performed on these variables?]
[Author: The columns below these subheads are not
percents, so “percent” should not be used in the sub-
head. Can we shorten these subheads to key words
(i.e., “Diet and Nutritional Supplements”) only?]
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or radiation were associated with higher CAM use and high
satisfaction with one’s primary physician was associated
with less frequent use.
Discussion
In this study of 105 female patients who had undergone
breast cancer surgery, CAM use was frequent. In general,
mainstream CAM therapies, such as vitamins and mineral
supplementation as well as prayer and spiritual healing, were
used most frequently. Still, a substantial percentage of par-
ticipants used less conventional stress-reduction techniques
as well as antioxidant supplementation. This study’s partici-
pants used more diet and nutritional supplements (63%),
compared to Boon et al. (2000), who reported 50% used vita-
mins and minerals; Lee et al. (2000), who reported 27% use of
dietary therapies in ethnic groups; Bennett and Lengacher
(1999), who reported 28% vitamin use in rural patients with
cancer; and VandeCreek et al. (1999), who reported use of
megavitamins for 23% of their participants. The use of
stress-reducing CAM therapies was consistent with other
studies. In this study, prayer was used most (49%); however,
it was used less than reported by VandeCreek et al., who
found that 76% of women with breast cancer used prayer.
Bennett and Lengacher found that 60% used prayer, and
Balneaves et al. (1999) found that 54% used spiritual and
faith healing. CAM use appears to vary across reported stud-
ies, and differences in use could be related to reporting of the
specific category, which is different for all studies. The data
indicated that patients with breast cancer commonly use
some CAM therapies; however, a consistent survey tool for
all studies that measures specific CAM therapies is not avail-
able. Thus, the weight of available evidence currently sug-
gests that patients with breast cancer routinely use CAM, but
small study samples and the use of different survey instru-
mentation undoubtedly contribute to the substantial varia-
tion in prevalence estimates across studies.
Clinical Implications of Findings
A large percentage of CAM therapy users did not discuss
CAM use with their physicians. This was true particularly for
stress-reducing techniques (e.g., art therapy, music therapy,
guided imagery) and traditional and ethnic medicines (e.g.,
aromatherapy, massage), although relatively more women
were willing to discuss the use of diet and nutritional supple-
ments with their healthcare providers. This lack of disclosure
is similar to findings by Adler and Fosket (1999) who learned
that only 54% of women with breast cancer who were treated
by alternative practitioners disclosed this practice to their
physicians. Conversely, 94% disclosed details of their bio-
medical treatments with their CAM practitioners.
Patients with breast cancer generally may perceive stress-
reduction and physical manipulation techniques as either
being less harmful or unaccepted as verified treatments by
healthcare providers; therefore, they do not share that they are
engaged in these therapies. Therapies that involve the con-
sumption of supplements could be perceived as affecting
current conventional treatments, and this heightened percep-
tion may increase communication with physicians related to
use of these supplements. Although this potentially en-
hanced awareness and communication is encouraging, the
current study’s data also suggest that patient-to-physician
communications concerning ongoing CAM use have consid-
erable room for improvement. If patients are not always forth-
coming concerning CAM use, healthcare providers need to
develop techniques to introduce discussion of CAM use and
encourage this communication as part of the routine assess-
ment process.
A second important finding of this study was that
women’s education level and chemotherapy treatments seem
to be associated with CAM use. Women with more than a
high school education appear to be more frequent users of
CAM therapies. This finding is consistent to those of Astin
(1998), Boon et al. (2000), and Sparber et al. (2000), who
found that women with high educational backgrounds were
more frequent users of CAM, tended to be younger, and re-
ported that CAM use was more congruent with their philoso-
phy of life (Astin). Logically, women who are more educated
may be more informed, on average, of the potential benefits
of CAM therapies, as well as equipped with greater financial
resources to seek out CAM therapies that involve significant
costs.
The current study’s finding that prior receipt of chemo-
therapy and, to a lesser extent, radiation appear to be associ-
ated with more frequent CAM use may relate to overall dis-
ease severity and a concomitant increased perception of
susceptibility of illness. Boon et al. (2000) also reported that
users of CAM were more likely to have had chemotherapy.
The hypothesis of potential increased perceived susceptibil-
ity among chemotherapy recipients is consistent with ele-
ments of the Health Belief Model of conditions that influ-
ence health behavior (Janz & Becker, 1984; Rosenstock,
1974a, 1974b). This potential increased perceived suscepti-
bility may have important clinical implications for patients
undergoing chemotherapy, particularly if use of a CAM
therapy has beneficial effects or if it adversely affects the ef-
ficacy and safety of chemotherapy. Because CAM therapies
routinely appear to be used adjunct to other conventional
treatments, clinical trials should be conducted in controlled
settings to evaluate the effects of various adjunct CAM thera-
pies. Importantly, the widespread CAM use actually may
hinder accrual to clinical trials. A more global hindrance is
the lack of multidisciplinary infrastructure to conduct inves-
tigations because few centers and research teams are experi-
enced in CAM therapies (Tagliaferri, Cohen, & Tripathy,
2001). Currently, the National Institutes of Health is begin-
ning to study effects of CAM therapies on various popula-
tions, and NCI is focusing on clinical trials involving people
with cancer and use of CAM.
Finally, the current study’s data suggest the possibility
that higher overall CAM use may be more likely among
people who are not highly satisfied with their primary phy-
sicians. This apparent trend requires further investigation
and is consistent with the work of Boon et al. (1999), who
reported that one reason women with breast cancer use CAM
is because of bad experiences with conventional medicine.
If women had physicians who supported their use of CAM,
they looked to them for guidance; however, if women found
that CAM use was discouraged or their physicians did not
want to know what they were taking, rapport was affected.
Some physicians belied it was a waste of money to use
CAM. In addition, Boon et al. (2000) found that a signifi-
cant difference existed in perceived attitudes of CAM practi-
tioners as compared to conventional practitioners. CAM prac-
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titioners were viewed to provide more emotional support and
listen carefully to what patients were saying. Also, Boon et al.
(2000) reported that women with breast cancer who used
CAM therapies were less likely to believe that conventional
treatments would cure their cancer and that conventional
therapies have side effects [Author: Please confirm—the
women were less likely to believe that conventional thera-
pies have side effects?].
Study Limitations
This study is based on a relatively small sample of 105
women. Thus, the study was underpowered to detect associa-
tions of modest size. As a result, the researchers were able to
identify only a very limited set of demographic and clinical
factors that appear to be associated with CAM use. In addi-
tion, the study population was almost entirely Caucasian and
did not include many women of low socioeconomic status.
Thus, the results presented here may not generalize to many
other breast cancer treatment settings. Finally, the instrument
used to measure CAM use is still undergoing revision, al-
though it previously has demonstrated adequate reliability.
Conclusions and Implications
for Nursing Practice
CAM use is common among women following diagnosis
with breast cancer. Variation in education and use of chemo-
therapy appears to be associated with the relative frequency
of CAM use, as well as in patients’ communication of this
use with their physicians. Use of CAM following diagnosis of
breast cancer varied for specific types of CAM, but most
women used vitamins and minerals on a regular basis (68%)
followed by stress-reducing techniques (66%). Most of the
users of diet and nutritional supplements did discuss this use
with their providers, indicating that the knowledge of effects
and side effects of nutritional supplements would be essen-
tial for clinical practice. In contrast, use of stress-reducing
techniques was not discussed with providers. This has impli-
cations for education and practice in that some of the stress-
reducing techniques were used prior to diagnosis, but partici-
pation in support groups and guided imagery was new.
Further investigation is needed to identify specific correlates
and circumstances in which CAM therapies are being sought
out and, in particular, if under certain circumstances such use
adversely interferes with conventional breast cancer treat-
ment regimens.
If oncology nurses can determine what CAM therapies
women are using, then they can further educate patients
about which therapies may be useful in relieving patients’
symptoms and psychological distress. Oncology nurses have
a great opportunity to implement varied CAM therapies that
may facilitate conventional treatments. For nurses, this may
mean specialized training and education to provide these
therapies; however, nurses are in an excellent position to pro-
vide education and knowledge related to CAM therapies so
patients feel and believe they are receiving a holistic ap-
proach to their diagnosis of breast cancer.
Author Contact: Cecile A. Lengacher, RN, PhD, can be reached at
[Au from RM: You did not sign for us to use your e-mail ad-
dress as contact, correct?]
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